Update in myopia and treatment strategy of atropine use in myopia control

10.1038/s41433-018-0139-7

Saved in:
Bibliographic Details
Main Authors: Wu, P.-C, Chuang, M.-N, Choi, J, Chen, H, Wu, G, Ohno-Matsui, K, Jonas, J.B, Cheung, C.M.G
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Review
Published: Nature Publishing Group 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/175096
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-175096
record_format dspace
spelling sg-nus-scholar.10635-1750962023-09-01T09:27:06Z Update in myopia and treatment strategy of atropine use in myopia control Wu, P.-C Chuang, M.-N Choi, J Chen, H Wu, G Ohno-Matsui, K Jonas, J.B Cheung, C.M.G DUKE-NUS MEDICAL SCHOOL atropine atropine mydriatic agent childhood disease disease control eye refraction human hypermetropia myopia pathophysiology Review treatment planning treatment response drug effect myopia physiology practice guideline standards treatment outcome Atropine Humans Mydriatics Myopia Practice Guidelines as Topic Refraction, Ocular Treatment Outcome 10.1038/s41433-018-0139-7 Eye (Basingstoke) 33 1 Mar-13 2020-09-09T03:43:40Z 2020-09-09T03:43:40Z 2019 Review Wu, P.-C, Chuang, M.-N, Choi, J, Chen, H, Wu, G, Ohno-Matsui, K, Jonas, J.B, Cheung, C.M.G (2019). Update in myopia and treatment strategy of atropine use in myopia control. Eye (Basingstoke) 33 (1) : Mar-13. ScholarBank@NUS Repository. https://doi.org/10.1038/s41433-018-0139-7 0950-222X https://scholarbank.nus.edu.sg/handle/10635/175096 Nature Publishing Group Unpaywall 20200831
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic atropine
atropine
mydriatic agent
childhood disease
disease control
eye refraction
human
hypermetropia
myopia
pathophysiology
Review
treatment planning
treatment response
drug effect
myopia
physiology
practice guideline
standards
treatment outcome
Atropine
Humans
Mydriatics
Myopia
Practice Guidelines as Topic
Refraction, Ocular
Treatment Outcome
spellingShingle atropine
atropine
mydriatic agent
childhood disease
disease control
eye refraction
human
hypermetropia
myopia
pathophysiology
Review
treatment planning
treatment response
drug effect
myopia
physiology
practice guideline
standards
treatment outcome
Atropine
Humans
Mydriatics
Myopia
Practice Guidelines as Topic
Refraction, Ocular
Treatment Outcome
Wu, P.-C
Chuang, M.-N
Choi, J
Chen, H
Wu, G
Ohno-Matsui, K
Jonas, J.B
Cheung, C.M.G
Update in myopia and treatment strategy of atropine use in myopia control
description 10.1038/s41433-018-0139-7
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Wu, P.-C
Chuang, M.-N
Choi, J
Chen, H
Wu, G
Ohno-Matsui, K
Jonas, J.B
Cheung, C.M.G
format Review
author Wu, P.-C
Chuang, M.-N
Choi, J
Chen, H
Wu, G
Ohno-Matsui, K
Jonas, J.B
Cheung, C.M.G
author_sort Wu, P.-C
title Update in myopia and treatment strategy of atropine use in myopia control
title_short Update in myopia and treatment strategy of atropine use in myopia control
title_full Update in myopia and treatment strategy of atropine use in myopia control
title_fullStr Update in myopia and treatment strategy of atropine use in myopia control
title_full_unstemmed Update in myopia and treatment strategy of atropine use in myopia control
title_sort update in myopia and treatment strategy of atropine use in myopia control
publisher Nature Publishing Group
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/175096
_version_ 1778169849976979456